"Nifedipine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Descriptor ID |
D009543
|
| MeSH Number(s) |
D03.383.725.203.540
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nifedipine".
Below are MeSH descriptors whose meaning is more specific than "Nifedipine".
This graph shows the total number of publications written about "Nifedipine" by people in this website by year, and whether "Nifedipine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 2 | 2 |
| 2003 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2008 | 0 | 2 | 2 |
| 2020 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nifedipine" by people in Profiles.
-
Pregnancy Outcomes of Nifedipine Compared With Labetalol for Oral Treatment of Mild Chronic Hypertension. Obstet Gynecol. 2024 Jul 01; 144(1):126-134.
-
Gestational weight gain among gravidae with hypertension receiving labetalol versus nifedipine. Pregnancy Hypertens. 2022 06; 28:121-122.
-
Identification of the hypertension drug niflumic acid as a glycine receptor inhibitor. Sci Rep. 2020 08 19; 10(1):13999.
-
Intravenous labetalol versus oral nifedipine for acute hypertension in pregnancy: effects on cerebral perfusion pressure. Am J Obstet Gynecol. 2020 09; 223(3):441.e1-441.e8.
-
Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tamsulosin) (the SUSPEND trial). Health Technol Assess. 2015 Aug; 19(63):vii-viii, 1-171.
-
Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial. Lancet. 2015 Jul 25; 386(9991):341-9.
-
Use of drug therapy in the management of symptomatic ureteric stones in hospitalized adults (SUSPEND), a multicentre, placebo-controlled, randomized trial of a calcium-channel blocker (nifedipine) and an a-blocker (tamsulosin): study protocol for a randomized controlled trial. Trials. 2014 Jun 20; 15:238.
-
Prematurity prevention: the role of acute tocolysis. Curr Opin Obstet Gynecol. 2009 Apr; 21(2):136-41.
-
CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats. Clin Exp Pharmacol Physiol. 2009 Feb; 36(2):169-75.
-
Human stanniocalcin-1 blocks TNF-alpha-induced monolayer permeability in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol. 2008 May; 28(5):906-12.